Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Identification of small molecule compounds that inhibit the HIF-1 signaling pathway.

Xia M, Bi K, Huang R, Cho MH, Sakamuru S, Miller SC, Li H, Sun Y, Printen J, Austin CP, Inglese J.

Mol Cancer. 2009 Dec 9;8:117. doi: 10.1186/1476-4598-8-117.

2.

Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Vadlapatla RK, Vadlapudi AD, Mitra AK.

Curr Drug Targets. 2013 Jul;14(8):919-35. Review.

3.

Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.

Martínez-Sánchez G, Giuliani A.

J Exp Clin Cancer Res. 2007 Mar;26(1):39-50. Review.

PMID:
17550131
4.

Hypoxia inducible factor pathways as targets for functional foods.

Losso JN, Bawadi HA.

J Agric Food Chem. 2005 May 18;53(10):3751-68. Review.

PMID:
15884793
5.

Hypoxia and the HIF system in kidney disease.

Nangaku M, Eckardt KU.

J Mol Med (Berl). 2007 Dec;85(12):1325-30. Review.

PMID:
18026918
6.

Hypoxia inducible factor-1: a novel target for cancer therapy.

Belozerov VE, Van Meir EG.

Anticancer Drugs. 2005 Oct;16(9):901-9. Review.

PMID:
16162966
7.

HIF-1α pathway: role, regulation and intervention for cancer therapy.

Masoud GN, Li W.

Acta Pharm Sin B. 2015 Sep;5(5):378-89. doi: 10.1016/j.apsb.2015.05.007. Review.

8.

Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.

Burroughs SK, Kaluz S, Wang D, Wang K, Van Meir EG, Wang B.

Future Med Chem. 2013 Apr;5(5):553-72. doi: 10.4155/fmc.13.17. Review.

9.

Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).

Nagle DG, Zhou YD.

Curr Drug Targets. 2006 Mar;7(3):355-69. Review.

10.

Hypoxia inducible factor-1 as a target for neurodegenerative diseases.

Zhang Z, Yan J, Chang Y, ShiDu Yan S, Shi H.

Curr Med Chem. 2011;18(28):4335-43. Review.

Items per page

Supplemental Content

Support Center